Navigation Links
Advances in personalized medicine take center stage
Date:4/27/2010

Kansas City, MO April 28, 2010 Many of the world's leading experts in pediatric pharmacogenomics and personalized medicine are gathering today at a first-of-its-kind conference in Kansas City to change the way childhood diseases and illnesses are treated. The goal of the conference, hosted by Children's Mercy Hospitals and Clinics, is to apply genomic tools to medical problems to tailor treatment to the unique make-up of pediatric patients and improve outcomes.

"Personalized medicine uses recent advancements in genomics and molecular data to help us give the right medication to the right patient, in the right dosage, at the right time," said conference organizer Stephen Spielberg, MD, PhD, Director of the Children's Mercy Center for Personalized Medicine and Therapeutic Innovation; Marion Merrell Dow Chair in Pediatric Pharmacogenomics; and Professor of Pediatrics, University of Missouri-Kansas City School of Medicine. "Currently, many types of medications work for only about half of the people who take them, so personalized medicine has the potential to revolutionize the way we treat illness."

At the April 28-30 conference, experts from academia, government and the private sector in the US, Canada and Japan will exchange knowledge centering on clinical applications, bioethics and development of pediatric personalized medicine programs. The conference will begin on Wednesday evening, April 28 at 6 p.m., with a keynote speech delivered by Gregory Downing, DO, PhD, Office of the Secretary, US Department of Health and Human Services.

Among the clinical applications to be discussed are some of the research programs being conducted at Children's Mercy addressing important patient challenges, such as:

  • Applying genomic strategies to improve the safety and efficacy of medications used to treat cancer in children
  • Improving the effectiveness and benefit/risk ratio of a common therapeutic agent in treating Juvenile Idiopathic Arthritis, where inter-patient variability results in up to 40 percent of patients failing to achieve remission
  • Uncovering genetic and developmental factors contributing to the risk of serious adverse drug reactions in children
  • Identifying a non-invasive marker for inflammation related to asthma, enabling physicians to accurately predict if patients will respond to steroid treatment, and if not, to guide them toward more useful therapies
  • Using genetic biomarkers to predict which newborns are at risk for developing hyperbilirubinemia, the single most common reason for newborn re-hospitalizations, accounting for up to 85 percent of readmissions during the first two weeks of life

The conference also will facilitate exchanges that help navigate concerns posed by personalized medicine. "Genetic discrimination, cost-benefit analysis, universal standards for managing genomic information in electronic medical records, biobanking, and strategies to educate practitioners and patients are all hot topics in personalized medicine that we will focus on at the conference," said conference organizer J. Steven Leeder, PharmD, PhD, Division Chief, Clinical Pharmacology and Medical Toxicology; Marion Merrell Dow Endowed Chair in Pediatric Clinical Pharmacology; and Professor of Pediatrics and Pharmacology, UMKC School of Medicine. "The importance of this area is also recognized by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has approved a grant to provide partial support for the meeting."


'/>"/>

Contact: Sherry D. Gibbs
SDGibbs@cmh.edu
816-346-1340
GolinHarris NY
Source:Eurekalert

Related medicine news :

1. Leading Orthopaedic Surgeon and Regenerative Medical Authority Dr. Thomas A. Einhorn Advances Adult Stem Cell Therapy To Eliminate Hip Replacement Surgery
2. South Carolina Senate Banking & Insurance Committee Advances Medigap Bill to Full Senate by Overwhelming Vote
3. Fifty years of the light fantastic: Laser advances spark scientific progress
4. Greenway Medical Technologies Advances Patient-Provider Benefits
5. SeqWright Advances Genomic Discovery With Isilon IQ
6. Neutrons poised to play big role in future scientific advances
7. Senate Committee Advances Disastrous Idaho Health Freedom Act
8. Sunquest Advances Investment in Innovations Team
9. Large donation advances cancer research
10. Medical Advances Revolutionize Hip Replacement and Knee Replacement
11. Gene Findings in Autism, Blindness at Childrens Hospital Top National Lists of Medical Advances in 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: